Topics

Articles

To avoid anti-kickback litigation with government, pharma companies need a defensible position on FMV assessments

Defending Fair Market Value (FMV) Assessments

The growing number of states with laws now are joined by the “51st state”: the federal government

With Healthcare Reform, Aggregate Spending Jumps as a Regulatory Priority

Growing digitization of patient data could break the threshold to better adherence to medication therapies

Medication adherence could get an EHR boost

Improving Outcomes Research Protocols

Kaiser Permanente files a citizen’s petition to revise FDA’s process of imposing REMS programs, also objects to restrictions on wholesale-distribution

Healthcare Provider Pushes Back on FDA's REMS Policies

Sharps Compliance Corp. lauds California law to raise the profile of proper consumer disposal of used sharps. Next up: unused pharmaceutical returns

Medical-Waste Processor Bids to Assist Manufacturers Who Distribute Injectables to the Home-Health Market

FDA sets a precedent for granting generic approvals even when initial litigation goes against the generic manufacturer

Generic Manufacturers Gain Another Advantage in Disputing Drug Patents

Nearly 30% of acquiring companies do not evaluate FCPA risks prior to an acquisition

Risky Business: What Life Sciences Need to Know About the US Foreign Corrupt Practices Act Before an Acquisition

Oncology drug development pipelines are overflowing, but the sky-high prices of these agents are turning reimbursement schemes, and the very practice of cancer medicine, on their heads

Oncology Drugs Add Promise, Stresses to Healthcare Delivery

CDC is depending on a new distribution process for ‘the largest vaccine distribution in history’

Legal and Regulatory